Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
TissueX Technologies logo — Boosting drug discovery efficiency with enhanced cell-based...

TissueX Technologies

Boosting drug discovery efficiency with enhanced cell-based assay predictability and quantification in preclinical development

Founded 2018 Seed Biotechnology, Pharmaceutical

General Information

Company Name TissueX Technologies
Founded Year 2018
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with TissueX Technologies. To contact TissueX Technologies, visit tissuextechnologies.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TissueX Technologies compare?

A PDF of TissueX Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TissueX Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TissueX Technologies

TissueX Technologies is a Toronto-based biotechnology company founded in 2018 with the aim of revolutionizing drug discovery. The company's slogan, "Boosting drug discovery efficiency with enhanced cell-based assay predictability and quantification in preclinical development," reflects its commitment to advancing the predictability and quantification power of cell-based assays used in preclinical drug development. The latest milestone in its journey is the Seed Round investment at 21 March 2019 from a notable investor, the University of Toronto. TissueX Technologies operates in the Biotechnology and Pharmaceutical industries, positioning itself at the forefront of innovation in these sectors.

Business keywords: Drug discovery, Cell-based assays, Preclinical development, Predictability, Quantification, TissueX Technologies, Toronto-based, Biomedical research, Innovation, Research and development, Pharmaceutical industry, Drug development, Biotech startup

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
University of Toronto
21 Mar 2019
Pre Seed Round Undisclosed 1
UTEST
UTEST
01 Jan 2018

TissueX Technologies Alternatives & Competitors

View All Alternatives
TissueX Technologies vs
iQ Biosciences
iQ Biosciences United States

Providing focused research support in the form of intelligent in-vitro and in-vivo bioservices and q...

24 employees
Biotechnology, Health Care
TissueX Technologies vs
Design Pharmaceuticals Inc.
Design Pharmaceuticals Inc. United States

Boundless GPCR drug discovery

Seed
3 employees
Biotechnology, Health Care
TissueX Technologies vs
Micar Innovation (Micar21)
Micar Innovation (Micar21) Bulgaria

Micar Innovation - Drug Discovery Factory for novel drug molecules (structure based in silico drug d...

3 employees
AI, Biotechnology
View all alternatives

FAQ About TissueX Technologies

Boosting drug discovery efficiency with enhanced cell-based assay predictability and quantification in preclinical development
TissueX Technologies was founded in 2018.
TissueX Technologies operates in Biotechnology and Pharmaceutical. Its work centres on Drug discovery, Cell-based assays, Preclinical development and Predictability.
TissueX Technologies has completed 2 funding rounds. The latest funding stage is Seed.
Top alternatives and competitors to TissueX Technologies include iQ Biosciences, Design Pharmaceuticals Inc., Micar Innovation (Micar21), NeuCyte, Modulus Discovery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TissueX Technologies and iQ Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TissueX Technologies, https://bouncewatch.com/company/tissuex-technologies, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes